Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03073928Unknown
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms). Primary endpoint: Duration of analgesia up to 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03073928.